StockData
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

InfuSystem Holdings, Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$13.74+0.34 (+2.54%)

Close on Oct 19, 2026

Market cap
$287.44M
P/E (TTM)
33.5
Dividend yield
–

InfuSystem statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison

Valuation

MeasureInfuSystemIndustry median
Market Cap$273.66M$230.55M
Enterprise Value$293.12M$202.97M
PE Ratio33.5133.40
PS Ratio1.913.11
PB Ratio4.633.14
P/TBV Ratio5.594.57
P/FCF Ratio11.9527.25
P/OCF Ratio11.7122.35

Enterprise value

MeasureInfuSystemIndustry median
EV / Sales2.052.92
EV / EBITDA11.1319.86
EV / EBIT22.0924.88
EV / FCF12.8027.85

Income (trailing twelve months)

MeasureInfuSystemIndustry median
Revenue$143.34M$102.39M
Gross Profit$82.35M$60.36M
Operating Income$13.27M-$4.31M
Pretax Income$12.21M-$2.26M
Net Income$8.54M-$6.57M
EBITDA$26.33M-$1.98M
EPS (Diluted)$0.41-$0.07

Margins

MeasureInfuSystemIndustry median
Gross Margin57.5%55.1%
Operating Margin9.26%-6.04%
Pretax Margin8.52%-4.11%
Profit Margin5.96%-10.5%
EBITDA Margin18.4%-2.67%
FCF Margin16.0%-0.30%

Returns

MeasureInfuSystemIndustry median
Return on Equity (ROE)15.0%-19.2%
Return on Assets (ROA)8.61%-13.3%
Return on Invested Capital (ROIC)11.7%-4.11%
Return on Capital Employed (ROCE)16.1%-9.07%

Growth

MeasureInfuSystemIndustry median
Revenue Growth (YoY)2.47%8.85%
Net Income Growth (YoY)68.4%10.6%
EPS Growth (YoY)78.3%10.6%
FCF Growth (YoY)-10.7%10.6%
Revenue Growth (3Y CAGR)9.28%7.08%
Revenue Growth (5Y CAGR)8.05%11.8%
EPS Growth (5Y CAGR)-17.3%7.64%

Balance sheet

MeasureInfuSystemIndustry median
Cash & Short-Term Investments$964.00K$37.33M
Total Debt$20.42M$72.66M
Net Cash (Debt)-$19.46M$3.92M
Net Cash Per Share-$0.98$0.28
Equity (Book Value)$59.15M$57.36M
Book Value Per Share$2.97$2.81
Tangible Book Value$48.95M$10.71M
Working Capital$22.97M$54.64M

Financial position

MeasureInfuSystemIndustry median
Current Ratio2.502.50
Quick Ratio1.841.54
Debt / Equity0.350.38
Debt / EBITDA0.782.31
Debt / FCF0.893.50
Net Debt / EBITDA0.741.53
Interest Coverage12.06-1.81

Cash flow (trailing twelve months)

MeasureInfuSystemIndustry median
Operating Cash Flow$23.37M-$653.46K
Capital Expenditures-$460.00K-$3.69M
Free Cash Flow$22.91M-$835.02K
FCF Per Share$1.15-$0.02

Efficiency

MeasureInfuSystemIndustry median
Asset Turnover1.440.59
Inventory Turnover10.902.21
Revenue Per Employee$303.03K$322.57K
Profits Per Employee$18.06K-$51.88K
Employee Count473185

Dividends and yields

MeasureInfuSystemIndustry median
Earnings Yield3.12%-6.91%
FCF Yield8.37%-0.56%
Buyback Yield2.86%0.78%
Shareholder Yield2.86%0.80%

Shares

MeasureInfuSystemIndustry median
Shares Outstanding19,917,20044,856,700
Shares Change (YoY)-2.21%3.35%
Shares Change (QoQ)-1.31%0.27%
Float17,497,20037,097,900
Shares Held by Insiders12.2%10.6%
Shares Held by Institutions79.1%63.5%

Taxes

MeasureInfuSystemIndustry median
Income Tax$3.67M$1.52M
Effective Tax Rate30.0%18.6%

Scores

MeasureInfuSystemIndustry median
Graham Number$5.23$34.37
Graham Upside-61.9%-57.7%
Altman Z-Score5.581.95
Piotroski F-Score85
Beneish M-Score-3.30-2.64

Calculated by StockData from InfuSystem's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.